|
BRAP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.967200E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.656600E-03 |
| Normal-vs-Stage2 |
3.426300E-02 |
| Normal-vs-Stage3 |
1.222280E-04 |
| Normal-vs-Stage4 |
1.82474999999016E-05 |
| Stage1-vs-Stage2 |
7.171400E-01 |
| Stage1-vs-Stage3 |
2.105600E-01 |
| Stage1-vs-Stage4 |
2.561800E-02 |
| Stage2-vs-Stage3 |
2.179800E-01 |
| Stage2-vs-Stage4 |
4.990000E-02 |
| Stage3-vs-Stage4 |
3.154200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.795400E-04 |
| Normal-vs-AfricanAmerican |
1.708390E-01 |
| Normal-vs-Asian |
9.681400E-03 |
| Caucasian-vs-AfricanAmerican |
2.894000E-01 |
| Caucasian-vs-Asian |
5.852200E-01 |
| AfricanAmerican-vs-Asian |
5.346400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.117290E-03 |
| Normal-vs-Female |
5.991100E-04 |
| Male-vs-Female |
9.559800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.144300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.279200E-03 |
| Normal-vs-Age(61-80Yrs) |
6.44929999999988E-05 |
| Normal-vs-Age(81-100Yrs) |
3.190200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.714200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.248000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.593000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.309200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.863400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.079400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.171500E-02 |
| Classical-VS-Follicular |
7.492400E-01 |
| Classical-VS-Other |
2.526800E-01 |
| Classical-VS-Normal |
2.038200E-03 |
| Tall-VS-Follicular |
1.945040E-01 |
| Tall-VS-Other |
8.018800E-01 |
| Tall-VS-Normal |
1.443000E-04 |
| Follicular-VS-Other |
4.522800E-01 |
| Follicular-VS-Normal |
1.058180E-02 |
| Other-VS-Normal |
3.142200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.820300E-04 |
| Normal-vs-N1 |
4.92370000004794E-06 |
| N0-vs-N1 |
4.407900E-02 |
|
|
